172
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements

, , , , &
Pages 89-93 | Published online: 05 Jun 2013

Figures & data

Table 1 Pre- versus post-KDQOL-36™ (version 1.3)

Table 2 Parameters variation over time

Figure 1 Average decrease in mean erythropoietin alpha dose.

Notes: The average decrease in mean erythropoeitin alpha dose between the losanges (blue), before treatment with vitamin B12 and the squares (red), after treatment with vitamin B12, with the corresponding trendlines.
Figure 1 Average decrease in mean erythropoietin alpha dose.